封面
市场调查报告书
商品编码
1214635

心电图(ECG)设备的市场规模:各产品,各导程类型,各携带,各最终用途-COVID-19影响分析,产业分析,地区展望,成长性,竞争市场占有率,预测(2023年~2032年)

Electrocardiogram (ECG) Devices Market Size, By Product, By Lead Type, By Portability, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 310 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球心电图(ECG)设备的市场规模,主要由于ECG设备的持续性技术性升级,到2032年大幅度扩大。

还有一般市民的健康受到高度关注,主要企业对研究开发举措的投资增加,促进市场成长。

本报告提供全球心电图(ECG)设备市场相关调查分析,市场分析,竞争情形,企业简介等系统性资讯。

目录

第1章 调查手法和范围

  • 产业报道
  • 市场范围和定义
  • 基本估计与工作
    • 资料收集
  • 预测参数
  • 在世界水准的COVID-19影响分析
  • 资料检验
  • 资料来源
    • 二级
    • 一级

第2章 摘要整理

  • 心电图(ECG)设备产业的全方位的摘要(2018年~2032年)
    • 事业趋势
    • 产品趋势
    • 导程类型趋势
    • 携带趋势
    • 最终用途趋势
    • 地区趋势

第3章 心电图(ECG)设备产业考察

  • 产业形势(100万美元)(2018年~2032年)
  • 产业的影响要素
    • 促进因素
    • 产业的潜在的风险、课题
  • 成长性分析
    • 各产品
    • 各导程
    • 各携带性
    • 各最终用途
  • COVID-19影响分析
  • 法规情形
    • 美国
    • 欧洲
  • 偿付情境
  • 技术形势
    • 今后的技术
  • 波特分析
  • PESTEL分析

第4章 竞争情形(2021年)

  • 简介
  • 企业矩阵分析
  • 策略仪表板

第5章 心电图(ECG)设备市场:各产品

  • 主要的产品趋势
  • 心电图诊断设备
    • 静态心电图
    • 压力时心电图
  • 心电图(ECG)设备的监测
    • 心电图监测
    • 置入式心臟监测
    • ECG遥测监测/心臟事件记录器
    • 其他

第6章 心电图(ECG)设备市场:各导程类型

  • 主要的导程类型趋势
  • 1芯类型
  • 3芯类型
  • 6芯类型
  • 12芯类型
  • 其他

第7章 心电图(ECG)设备市场:各携带性

  • 携带的主要趋势
  • 可携式设备
  • 非可携式设备

第8章 心电图(ECG)设备市场:各最终用途

  • 主要的最终用途趋势
  • 医院和诊所
  • 诊断中心
  • 门诊病人手术中心
  • 居家医疗
  • 其他

第9章 心电图(ECG)设备市场:各地区

  • 主要地区趋势
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 波兰
    • 瑞士
    • 荷兰
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
    • 印尼
  • 南美
    • 阿根廷
    • 巴西
    • 哥伦比亚
    • 墨西哥
  • 中东、非洲
    • 沙乌地阿拉伯
    • 南非
    • 以色列
    • 阿拉伯联合大公国

第10章 企业简介

  • AliveCor, Inc.
  • Allengers Medical Systems, Ltd.
  • Biotricity, Inc.
  • Bionet America, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • BPL Medical Technologies
  • Cardioline S.P.A
  • Fukuda Denshi Co., Ltd.
  • GE Healthcare
  • Hill-Rom Holdings, Inc.(Baxter)
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Spacelabs Healthcare(OSI Systems, Inc.)
简介目录
Product Code: 5425

Electrocardiogram (ECG) Devices Market is anticipated to expand substantially through 2032, primarily owing to the ongoing technical upgradation in ECG devices. These innovations are expected to assist healthcare professionals in treating and diagnosing patients accurately.

Besides, ECG helps measure the rhythm and heart rate, axis of the heart, and state of myocardial muscle, preventing heart attacks by analyzing heart parameters during the initial stage. Increasing health concerns among the general populace will fuel the market demand.

The constantly surging adoption of mobile and telemetry cardiac monitors, along with the rising investments made by the key players in R&D initiatives to develop and innovate technologically advanced electrocardiogram (ECG) devices, will drive market growth.

For instance, Samsung has announced built-in ECGs in its Galaxy Watch Active 2 and newer smartwatches. Reportedly, the owners of Galaxy Watch 5 and Galaxy Watch 5 Pro in Malaysia can use the Samsung Health Monitor app on their smartphones to analyze their ECG and blood pressure, enabling them to diagnose heart-related issues earlier and consult a doctor for possible remedies.

Overall, the electrocardiogram (ECG) devices industry is segmented in terms of product, lead, portability, end-use, and region.

Based on the product, the monitoring ECG devices segment would witness strong demand during the forecast timeframe owing to advantages such as diagnosing heart problems, monitoring heart function, and recording the electrical activity of heart for a prolonged period. In addition, the constant innovations in monitoring devices resulting in the introduction of easy-to-use and convenient wearable products will further stimulate market growth.

In terms of the lead, the single lead type segment accounted for over 8.5% market share in 2022. The segment will register sturdy growth owing to the rising government initiatives to improve patient care through faster diagnosis. Besides, single-lead ECG monitoring is being increasingly favored for recording ECG with handheld or wearable devices, which will further bolster the market.

Considering the portability, the portable device segment will grow considerably through 2032 owing to the increasing adoption of ECG devices for patients, along with better accuracy and faster outcomes. In addition, the easy accessibility of data to the patient and the installation of the latest technology in products will boost the market demand.

Based on end-use, the hospitals & clinics segment accounted for over 51% market share in 2022. The segmental growth will be driven by the rising prevalence of cardiovascular diseases, resulting in increased demand for ECG devices in hospitals & clinics.

Regionally, the North America electrocardiogram devices industry registered over 33.5% market share in 2022 and will further expand through 2032. Supporting government initiatives, increasing awareness regarding early-stage disease diagnosis, and developing technologically advanced ECG will propel regional market growth during the estimated timeframe.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Industry coverage
  • 1.2 Market scope and definitions
  • 1.3 Base estimates and working
    • 1.3.1 Data collection
  • 1.4 Forecast parameters
  • 1.5 COVID-19 impact analysis at global level
  • 1.6 Data validation
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Electrocardiogram (ECG) devices industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Lead type trends
    • 2.1.4 Portability trends
    • 2.1.5 End-use trends
    • 2.1.6 Regional trends

Chapter 3 Electrocardiogram (ECG) Devices Industry Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of cardiovascular diseases
      • 3.2.1.2 Rising elderly population
      • 3.2.1.3 Technological advancements in ECG devices
      • 3.2.1.4 Increasing adoption of mobile and telemetry cardiac monitors
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of advanced ECG devices
      • 3.2.2.2 Lack of skilled professionals
  • 3.3 Growth potential analysis
    • 3.3.1 By product
    • 3.3.2 By lead type
    • 3.3.3 By portability
    • 3.3.4 By end-use
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
  • 3.6 Reimbursement scenario
  • 3.7 Technology landscape
    • 3.7.1 Upcoming technologies
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Strategy dashboard

Chapter 5 Electrocardiogram (ECG) Devices Market, By Product

  • 5.1 Key product trends
  • 5.2 Diagnostic ECG machines
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.2 Market estimates and forecast, 2018 - 2032 ('000 Units)
    • 5.2.3 Resting ECG
      • 5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.3.2 Market estimates and forecast, 2018 - 2032 ('000 Units)
    • 5.2.4 Stress ECG
      • 5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.4.2 Market estimates and forecast, 2018 - 2032 ('000 Units)
  • 5.3 Monitoring ECG devices
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.2 Market estimates and forecast, 2018 - 2032 ('000 Units)
    • 5.3.3 Holter monitor
      • 5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.3.3.2 Market estimates and forecast, 2018 - 2032 ('000 Units)
    • 5.3.4 Implantable cardiac monitors
      • 5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.3.4.2 Market estimates and forecast, 2018 - 2032 ('000 Units)
    • 5.3.5 ECG telemetry monitoring / event monitoring
      • 5.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.3.5.2 Market estimates and forecast, 2018 - 2032 ('000 Units)
    • 5.3.6 Others
      • 5.3.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.3.6.2 Market estimates and forecast, 2018 - 2032 ('000 Units)

Chapter 6 Electrocardiogram (ECG) Devices Market, By Lead Type

  • 6.1 Key lead type trends
  • 6.2 Single lead type
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 3-lead type
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.4 6- lead type
    • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.5 12- lead type
    • 6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.6 Others
    • 6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Electrocardiogram (ECG) Devices Market, By Portability

  • 7.1 Key portability trends
  • 7.2 Portable device
    • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 7.2.2 Market estimates and forecast, 2018 - 2032 ('000 Units)
  • 7.3 Non-portable device
    • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 7.3.2 Market estimates and forecast, 2018 - 2032 ('000 Units)

Chapter 8 Electrocardiogram (ECG) Devices Market, By End-use

  • 8.1 Key end-use trends
  • 8.2 Hospitals & clinics
    • 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.3 Diagnostic centers
    • 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.4 Ambulatory surgical centers
    • 8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.5 Homecare settings
    • 8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.6 Others
    • 8.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 Electrocardiogram (ECG) Devices Market, By Region

  • 9.1 Key regional trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Poland
    • 9.3.7 Switzerland
    • 9.3.8 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Thailand
    • 9.4.7 Indonesia
  • 9.5 Latin America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Columbia
    • 9.5.4 Mexico
  • 9.6 MEA
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 Israel
    • 9.6.4 UAE

Chapter 10 Company Profiles

  • 10.1 AliveCor, Inc.
  • 10.2 Allengers Medical Systems, Ltd.
  • 10.3 Biotricity, Inc.
  • 10.4 Bionet America, Inc.
  • 10.5 Biotronik SE & Co. KG
  • 10.6 Boston Scientific Corporation
  • 10.7 BPL Medical Technologies
  • 10.8 Cardioline S.P.A
  • 10.9 Fukuda Denshi Co., Ltd.
  • 10.10 GE Healthcare
  • 10.11 Hill-Rom Holdings, Inc. (Baxter)
  • 10.12 Koninklijke Philips N.V.
  • 10.13 Medtronic plc
  • 10.14 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 10.15 Spacelabs Healthcare (OSI Systems, Inc.)